Please upgrade your Flash Player

Latest Update: Sunday, September, 07th 2008

Search Site


Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.

9/27/2007--Introduced.

Disapproves a specified rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.

Declares that such rule shall have no force or effect.

Latest Actions
  • 11/08/2007 - Referred to the Subcommittee on Health.
  • 10/03/2007 - Referred to the Subcommittee on Health.
  • 09/27/2007 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 09/27/2007 - Referred to House Energy and Commerce
  • 09/27/2007 - Referred to House Ways and Means
Bill Text
File name Last Updated
H.J.RES.54 Introduced in House09/29/2007